PTCT News and Press, PTC Therapeutics Inc. From 11/20/25

PTC Therapeutics to Host R&D Day PTC Therapeutics to Host R&D Day PR Newswire Event to take place on Dec. 2, 2025 in New York City WARREN, N.J. , Nov. 20, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will host an R&D...

2025-11-11 18:21:32 ET PTC Therapeutics, Inc. (PTCT) UBS Global Healthcare Conference 2025 November 11, 2025 3:30 PM EST... Read the full article on Seeking Alpha For further details see: PTC Therapeutics, Inc. (PTCT) Presents at UBS Global Healthcare Conference 2025 Transcript

2025-11-06 16:59:15 ET Shares of gene therapy concern Lexeo Therapeutics, Inc. ( LXEO ) have roughly tripled since a financing in May 2025, partly on the back of FDA alignment on a registrational trial for its LX2006 therapy. Announced on October 7th, its pivotal study...

2025-11-06 06:16:34 ET ... Read the full article on Seeking Alpha For further details see: PTC Therapeutics: Sephience Starts Well, But Translarna Is The Swing Factor

2025-11-05 04:21:23 ET More on PTC Therapeutics PTC Therapeutics, Inc. (PTCT) Q3 2025 Earnings Call Transcript PTC Therapeutics, Inc. (PTCT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) PTC Therapeutics, Inc. (PTCT) Presents At Can...

2025-11-05 04:20:38 ET PTC Therapeutics, Inc. (PTCT) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST... Read the full article on Seeking Alpha For further details see: PTC Therapeutics, Inc. (PTCT) Q3 2025 Earnings Call Transcript

2025-11-04 16:25:34 ET More on PTC Therapeutics PTC Therapeutics, Inc. (PTCT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) PTC Therapeutics, Inc. (PTCT) Presents At Cantor Global Healthcare Conference 2025 Transcript PTC Therapeuti...

PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results PR Newswire – Initiated US and EU launch of Sephience ™ (sepiapterin) –  – Strong initial Sephience uptake with global revenue of $19.6M and 521 start...

Advanced Energy Industries Inc. (AEIS) is expected to report $1.16 for Q3 2025 Neuropace Inc. (NPCE) is expected to report $-0.2 for Q3 2025 Oportun Financial Corporation (OPRT) is expected to report $0.2 for Q3 2025 trivago N.V. (TRVG) is expected to report $0.07 for Q3 2025 Alle...

PTC Therapeutics to Participate at Upcoming Investor Conferences PR Newswire WARREN, N.J. , Oct. 31, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences: UBS Global Healthcare Co...